InsiderFlow

TriSalus Life Sciences, Inc.

$4.12+0.01 (+0.37%)

Prev Close

$4.10

Open

$4.13

High

$4.23

Low

$3.98

Volume

126.5K

Market Cap

$175.0M

P/E

Div Yield

Over the past 12 months, insider activity at TriSalus Life Sciences, Inc. (TLSI) has been dominated by buying, with 5 insider purchases totaling $3.27M and 4 insider sales totaling $128.6K. The most recent insider transaction was by Gordon Gary B. (director), who purchased $40.0K worth of shares on Feb 23, 2026. TriSalus Life Sciences, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $175.0M.

Buys (12M)

5

$3.27M

Sells (12M)

4

$128.6K

Net Activity

Net Buyer

$3.14M

Active Insiders

9

last 12 mo

TLSI Price Chart

TLSI Insider Trading Activity

DateInsiderRoleTypeSharesAvg PriceValueShares After
Feb 23, 2026Gordon Gary B.directorBuy9,756$4.10$40.0K9,756
Feb 23, 2026Patience Davidofficer: Chief Financial OfficerBuy3,657$4.10$15.0K268,657
Feb 23, 2026Stansky Michael PDirectorBuy722,196$4.10$2.96M787,132
Feb 23, 2026Szela Mary Tdirector, officer: CEO and PresidentBuy30,487$4.10$125.0K773,289
Feb 23, 2026Valle WilliamdirectorBuy30,487$4.10$125.0K30,487
May 19, 2025Cox Bryan F.Chief of ResearchSell4,764$5.18$24.7K0
May 19, 2025Devlin JodiChief of Clinical OperationsSell4,764$5.18$24.7K0
May 19, 2025Marshak RichardChief Commercial OfficerSell6,597$5.18$34.2K0
May 19, 2025Stevens JenniferChief Regulatory OfficerSell8,704$5.18$45.1K0

TLSI Insider Buying Activity

The following table shows recent insider purchases of TriSalus Life Sciences, Inc. (TLSI) stock reported via SEC Form 4 filings.

DateInsiderRoleTypeSharesAvg PriceValueShares After
Feb 23, 2026Gordon Gary B.directorBuy9,756$4.10$40.0K9,756
Feb 23, 2026Patience Davidofficer: Chief Financial OfficerBuy3,657$4.10$15.0K268,657
Feb 23, 2026Stansky Michael PDirectorBuy722,196$4.10$2.96M787,132
Feb 23, 2026Szela Mary Tdirector, officer: CEO and PresidentBuy30,487$4.10$125.0K773,289
Feb 23, 2026Valle WilliamdirectorBuy30,487$4.10$125.0K30,487

TLSI Insider Selling Activity

The following table shows recent insider sales of TriSalus Life Sciences, Inc. (TLSI) stock reported via SEC Form 4 filings.

DateInsiderRoleTypeSharesAvg PriceValueShares After
May 19, 2025Cox Bryan F.Chief of ResearchSell4,764$5.18$24.7K0
May 19, 2025Devlin JodiChief of Clinical OperationsSell4,764$5.18$24.7K0
May 19, 2025Marshak RichardChief Commercial OfficerSell6,597$5.18$34.2K0
May 19, 2025Stevens JenniferChief Regulatory OfficerSell8,704$5.18$45.1K0

TLSI Insiders

Gordon Gary B.

director

Bought $40.0K
1 tradesLast: Feb 23, 2026
Patience David

officer: Chief Financial Officer

Bought $15.0K
1 tradesLast: Feb 23, 2026
Stansky Michael P

director

Bought $1.48M
2 tradesLast: Feb 23, 2026
Stansky Michael P

Director

Bought $1.48M
2 tradesLast: Feb 23, 2026
Szela Mary T

director, officer: CEO and President

Bought $125.0K
1 tradesLast: Feb 23, 2026
Valle William

director

Bought $125.0K
1 tradesLast: Feb 23, 2026
Cox Bryan F.

Chief of Research

Sold $24.7K
1 tradesLast: May 19, 2025
Devlin Jodi

Chief of Clinical Operations

Sold $24.7K
1 tradesLast: May 19, 2025
Marshak Richard

Chief Commercial Officer

Sold $34.2K
1 tradesLast: May 19, 2025
Stevens Jennifer

Chief Regulatory Officer

Sold $45.1K
1 tradesLast: May 19, 2025